Early Versus Late Anticoagulation for Acute Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of 17,380 Patients
Open Access
- 8 December 2025
- journal article
- review article
- Published by MDPI AG in Neurology International
- Vol. 17 (12) , 198
Abstract
Background/Objectives: The optimal timing for initiating oral anticoagulants (OACs) after acute ischemic stroke (AIS) in patients with atrial fibrillation (AF) remains uncertain due to potential risks of recurrent stroke and bleeding. This meta-analysis compares early versus late OAC initiation for recurrent ischemic stroke, major bleeding, intracranial hemorrhage (ICH), systemic embolism, and all-cause mortality. Methods: We conducted a meta-analysis of randomized controlled trials (RCTs), prospective, and retrospective observational studies. Data were pooled using random-effects models, and subgroup analyses were performed to assess outcomes by study design. Heterogeneity was quantified using I2 statistics. Results: A total of 17 studies were included. Early OAC initiation was associated with a significantly lower risk of recurrent ischemic stroke compared to late initiation (OR = 0.74, 95% CI [0.58, 0.95], p = 0.02), with moderate heterogeneity (I2 = 36%, p = 0.08). No significant difference was observed in ICH rates (OR = 0.74, 95% CI [0.41, 1.33], p = 0.32), major bleeding (OR = 1.48, 95% CI [0.51, 4.30], p = 0.47), or systemic embolism (OR = 0.65, 95% CI [0.33, 1.25], p = 0.20). All-cause mortality showed no difference between early and late initiation (OR = 1.00, 95% CI [0.72, 1.39], p = 0.99). Subgroup analyses were consistent with overall findings, and heterogeneity ranged from low to moderate across outcomes. Conclusions: Early initiation of OACs post-AIS in AF patients significantly reduces ischemic stroke recurrence without increasing risks of ICH, major bleeding, systemic embolism, or mortality. These findings support early anticoagulation strategies for selected patients.Keywords
Funding Information
- KAU Endowment (WAQF) at King Abdulaziz University, Jeddah, Saudi Arabia
This publication has 27 references indexed in Scilit:
- The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke: a real-world studyJournal of Neurology, 2023
- Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profileJournal of Neurology, 2021
- Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial FibrillationJournal of Stroke and Cerebrovascular Diseases, 2021
- Non‐vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta‐analysis of observational studiesClinical Cardiology, 2021
- The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its applicationJournal of Clinical Epidemiology, 2020
- Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event RiskAnnals of Neurology, 2020
- Timing to start anticoagulants after acute ischemic stroke with non-valvular atrial fibrillationJournal of the Neurological Sciences, 2020
- Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial FibrillationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Early Initiation of Anticoagulation with Direct Oral Anticoagulants in Patients after Transient Ischemic Attack or Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2016
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statementInternational Journal of Surgery, 2010